14 results
6-K
EX-99.1
BYSI
BeyondSpring Inc
15 Jun 20
Current report (foreign)
4:39pm
. In the COVID-19 pandemic, the ability to reduce severe neutropenia, which is directly linked to both infections and hospitalizations, has become increasingly
6-K
EX-99.1
BYSI
BeyondSpring Inc
11 Jun 20
BeyondSpring Reports First-Quarter 2020 Financial Results and Operational Update
4:15pm
to the physicians, patients and the healthcare system in the COVID-19 pandemic. We expect to reach the pre-specified interim analysis for PROTECTIVE-2 … , increased competition in the market, the impact of widespread health developments, including the recent COVID-19 pandemic, and the responses thereto, which
6-K
EX-99.1
BYSI
BeyondSpring Inc
16 Nov 20
Current report (foreign)
7:22am
risk patients (chemo FN rate20%) to intermediate risk patients (FN rate between 10-20%) to avoid hospital/ER visits during the COVID-19 pandemic
6-K
EX-99.1
BYSI
BeyondSpring Inc
1 Apr 21
Current report (foreign)
8:22am
/hospital visits. Due to the COVID-19 pandemic, the updated National Comprehensive Cancer Network (NCCN) guidelines expanded the use of prophylactic G-CSFs
F-3
d0lzxip3zh9c ss
2 Jul 21
Shelf registration (foreign)
4:06pm
424B5
hb80gmo9qo7
17 Nov 20
Prospectus supplement for primary offering
4:19pm
424B5
1wrj4rre
18 Jun 20
Prospectus supplement for primary offering
4:40pm
424B5
hoojqz3n5 p3c
19 Nov 20
Prospectus supplement for primary offering
4:12pm
424B5
w6aez0oahjmb3p
19 Jun 20
Prospectus supplement for primary offering
4:31pm
- Prev
- 1
- Next